Nebenwirkungen · NeoRecormon
NeoRecormon 500 IU solution for injection in pre-filled syringe NeoRecormon 2 000 IU solution for injection in pre-filled syringe NeoRecormon 3 000 IU solution for injection in pre-filled syringe NeoRecormon 4 000 IU solution for injection in pre-filled syringe NeoRecormon 5 000 IU solution for injection in pre-filled syringe NeoRecormon 6 000 IU solution for injection in pre-filled syringe NeoRecormon 10 000 IU solution for injection in pre-filled syringe NeoRecormon 20 000 IU solution for injection in pre-filled syringe NeoRecormon 30 000 IU solution for injection in pre-filled syringe · Abschnitt 4.8 · PDF-Seite 11–12
HOS-086037 · Präparat HOS-083248
11 Table 1: Adverse reactions attributed to the treatment with NeoRecormon in controlled clinical trials in CKD patients System organ class Adverse reaction Frequency Vascular disorders Hypertension Common Hypertensive crisis Uncommon Nervous system disorders Headache Common Blood and lymphatic Shunt thrombosis Rare system disorders Thrombocytosis Very rare
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2025-05-02T10:00:00Z · SHA-256 d4885cc4a4f4b8eee4e66452aecdcfd9e0cb2d83ca77d038cff33e2a87f9cdac · Passage b51b23dbf5f018a5efa8e1457ad1ce7248b0bf165ae1211f51f17a67b6402bf4 · Zeichen 3336–3893 im Abschnitt